Long-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Long-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysis

Published:2015-08-03 Issue:8 Volume:20 Page:1153-1159
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Horita Nobuyuki¹²,Miyazawa Naoki¹,Tomaru Koji¹,Inoue Miyo¹,Kaneko Takeshi²

Affiliation:

1. Department of Respiratory Medicine; Saiseikai Yokohamashi Nanbu Hospital; Yokohama Japan

2. Department of Pulmonology; Yokohama City University Graduate School of Medicine; Yokohama Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12603/fullpdf

Reference32 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) The Global Strategy for the Diagnosis, Management and Prevention of COPD 2014 http://www.goldcopd.org/

2. QVA149 (indacaterol/glycopyrronium fixed-dose combination): a review of its use in patients with chronic obstructive pulmonary disease;Frampton;Drugs,2014

3. Indacaterol/glycopyrronium bromide fixed-dose combination for the treatment of COPD;Schachter;Drugs Today (Barc.),2013

4. Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease;Nannini;Cochrane Database Syst. Rev.,2013

5. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD;Hanania;Pulm. Pharmacol. Ther.,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisión narrativa de la terapia inhalatoria en la EPOC;Medicina de Familia. SEMERGEN;2021-09

2. Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review;Respiratory Research;2019-12

3. El tratamiento broncodilatador en la prevención de las exacerbaciones de la EPOC;Medicina de Familia. SEMERGEN;2019-10

4. Pharmacological treatment of COPD – New evidence;Pulmonology;2019-03

5. Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease;Respiratory Medicine: X;2019